These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8476475)

  • 1. Direct stimulation of urokinase, plasmin, and collagenase by meperidine: a possible mechanism for the ability of meperidine to enhance cervical effacement and dilation.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Am J Perinatol; 1993 Mar; 10(2):130-4. PubMed ID: 8476475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
    Durko M; Brodt P
    Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator activity is decreased in rat gingiva during diabetes.
    Chang K; Rani AS; Chang K; Kumar S
    J Periodontol; 1996 Aug; 67(8):743-47. PubMed ID: 8866312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and biomechanical characteristics of rat cervical ripening are not consistent with increased collagenase activity.
    Buhimschi IA; Dussably L; Buhimschi CS; Ahmed A; Weiner CP
    Am J Obstet Gynecol; 2004 Nov; 191(5):1695-704. PubMed ID: 15547544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
    Ossowski L
    Cancer Res; 1992 Dec; 52(24):6754-60. PubMed ID: 1333882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional assay of plasminogen activator by hydrolysis of 14C-globin.
    Finci Z; Nachshon I; Sharoni Y; Mayer M
    Exp Hematol; 1986 May; 14(4):293-7. PubMed ID: 2938980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
    J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
    Gils A; Knockaert I; Declerck PJ
    Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
    Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ; Kingston IB; Anderson S
    Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmin-catalyzed proteolysis in colorectal neoplasia.
    Delbaldo C; Cunningham M; Vassalli JD; Sappino AP
    Cancer Res; 1995 Oct; 55(20):4688-95. PubMed ID: 7553650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.
    Carmeliet P; Moons L; Lijnen R; Baes M; Lemaître V; Tipping P; Drew A; Eeckhout Y; Shapiro S; Lupu F; Collen D
    Nat Genet; 1997 Dec; 17(4):439-44. PubMed ID: 9398846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of plasmin activity by aspirin.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Thromb Haemost; 1991 Apr; 65(4):389-93. PubMed ID: 1829277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
    Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
    Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.